[go: up one dir, main page]

DK3297666T3 - Molekylær adjuvans og vaccine - Google Patents

Molekylær adjuvans og vaccine Download PDF

Info

Publication number
DK3297666T3
DK3297666T3 DK16725105.7T DK16725105T DK3297666T3 DK 3297666 T3 DK3297666 T3 DK 3297666T3 DK 16725105 T DK16725105 T DK 16725105T DK 3297666 T3 DK3297666 T3 DK 3297666T3
Authority
DK
Denmark
Prior art keywords
adjuvance
vaccine
molecular
molecular adjuvance
Prior art date
Application number
DK16725105.7T
Other languages
English (en)
Inventor
Alcolea Pedro José Alcolea
Ayala Ana María Alonso
Rodríguez De Vera Vicente Emilio Larraga
Original Assignee
Consejo Superior Investigacion
Cz Veterinaria S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior Investigacion, Cz Veterinaria S A filed Critical Consejo Superior Investigacion
Application granted granted Critical
Publication of DK3297666T3 publication Critical patent/DK3297666T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/008Leishmania antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53DNA (RNA) vaccination
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55561CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16725105.7T 2015-05-22 2016-05-23 Molekylær adjuvans og vaccine DK3297666T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15382273 2015-05-22
PCT/EP2016/061621 WO2016188973A1 (en) 2015-05-22 2016-05-23 Molecular adjuvant and vaccine

Publications (1)

Publication Number Publication Date
DK3297666T3 true DK3297666T3 (da) 2019-08-26

Family

ID=53298307

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16725105.7T DK3297666T3 (da) 2015-05-22 2016-05-23 Molekylær adjuvans og vaccine

Country Status (6)

Country Link
US (2) US10568960B2 (da)
EP (1) EP3297666B1 (da)
DK (1) DK3297666T3 (da)
ES (1) ES2747748T3 (da)
PT (1) PT3297666T (da)
WO (1) WO2016188973A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024180189A1 (en) * 2023-03-01 2024-09-06 Intervet International B.V. Dna vaccine for fish against salmonid alphavirus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60500673A (ja) 1983-03-08 1985-05-09 コモンウエルス セラム ラボラトリ−ズ コミツシヨン 抗原活性を有するアミノ酸配列
US20050112713A1 (en) 1996-08-28 2005-05-26 Affinium Pharmaceuticals, Inc. Methods of using Fab I and compounds modulating Fab I activity
CA2319115A1 (en) * 1998-01-23 1999-07-29 Trustees Of Tufts College Methods for identifying antimicrobial peptides that interact with enoyl acp reductase
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
JP4913587B2 (ja) 2006-12-28 2012-04-11 雪印メグミルク株式会社 ペプチドおよびタンパク質定量法
WO2008146100A1 (en) 2007-06-01 2008-12-04 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for absolute quantification of polypeptides
CN102695799A (zh) * 2009-09-27 2012-09-26 Opx生物工艺学公司 用于制备3-羟基丙酸和其它产物的方法
KR101992502B1 (ko) 2011-05-12 2019-06-24 제넨테크, 인크. 프레임워크 시그너처 펩티드를 사용하여 동물 샘플에서 치료 항체를 검출하기 위한 다중 반응 모니터링 lc-ms/ms 방법

Also Published As

Publication number Publication date
EP3297666B1 (en) 2019-07-03
EP3297666A1 (en) 2018-03-28
US11179462B2 (en) 2021-11-23
PT3297666T (pt) 2019-09-06
WO2016188973A1 (en) 2016-12-01
US20180289796A1 (en) 2018-10-11
ES2747748T3 (es) 2020-03-11
US10568960B2 (en) 2020-02-25
US20200360512A1 (en) 2020-11-19

Similar Documents

Publication Publication Date Title
IL284348A (en) Hiv pre-immunization and immunotherapy
DK3872085T5 (da) Stam-virussekvenser og anvendelser heraf
DK3354282T3 (da) Glycan-terapeutiske midler og relaterede fremgangsmåder deraf
DK3368534T3 (da) Valbenazin-ditosylat og polymorfer deraf
DK3393510T3 (da) Zikavirusvaccine
DK3448386T3 (da) Isoquinolin-3-ylcarboxamider og fremstilling og anvendelse deraf
DK3725357T3 (da) Opholdsstrukturer og relaterede fremgangsmåder
DK3283106T3 (da) Terapeutiske antistoffer og anvendelser deraf
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3218358T3 (da) Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner
PL3550023T3 (pl) Oligomery i koniugaty oligomerów
BR112016016289A2 (pt) heteroaris e usos dos mesmos
DK3018183T3 (da) Halogenolefinbaseret sammensætning og anvendelse deraf
DK3236991T3 (da) Fgf21-derivater og anvendelser deraf
DK3161139T3 (da) Tlr-4-specifikke aptamerer og anvendelser heraf
DK3209773T3 (da) Prolintolerante tripeptidylpeptidaser og anvendelser deraf
DK3128005T3 (da) Sirp-alfa-variantkonstruktioner og anvendelser deraf
DK3346056T3 (da) Rengøringssystem og fremgangsmåde
DK3265641T3 (da) Stigørenhed og fremgangsmåde
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
DK3337506T3 (da) Kombinationer og anvendelser deraf
DK3365321T3 (da) Solabegron-zwitterion og anvendelser deraf
DK3236934T3 (da) Farmaceutisk sammensætning, fremstilling og anvendelser deraf
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3231793T3 (da) Dihydropyromidin-2-on-forbindelser og medicinske anvendelser deraf